Your browser is no longer supported. Please, upgrade your browser.
BriaCell Therapeutics Corp.
Index- P/E- EPS (ttm)- Insider Own23.64% Shs Outstand14.33M Perf Week-6.20%
Market Cap136.59M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float11.68M Perf Month-3.25%
Income- PEG- EPS next Q- Inst Own43.90% Short Float16.29% Perf Quarter42.03%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.88 Perf Half Y85.05%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year121.02%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range2.81 - 12.47 Perf YTD128.54%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-23.58% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low238.56% ATR0.96
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)50.16 Volatility18.05% 9.63%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.98 Prev Close9.18
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.16M Price9.53
Recom- SMA20-4.44% SMA508.35% SMA20064.78% Volume2,163,513 Change3.81%
Nov-18-21 09:00AM  
Nov-12-21 09:00AM  
Nov-08-21 05:59AM  
Nov-05-21 09:00AM  
Nov-02-21 09:00AM  
Oct-22-21 06:00AM  
Oct-05-21 09:00AM  
Sep-23-21 08:00AM  
Sep-22-21 09:00AM  
Sep-16-21 09:00AM  
Sep-09-21 09:00AM  
Sep-01-21 09:15AM  
Aug-23-21 08:00AM  
Aug-19-21 08:00AM  
Aug-16-21 08:30AM  
Jul-14-21 07:22AM  
Jul-12-21 08:00AM  
Jul-08-21 11:20AM  
Jun-16-21 08:05AM  
Jun-10-21 08:05AM  
Jun-09-21 08:05AM  
Jun-07-21 07:50PM  
Jun-03-21 10:31AM  
Jun-02-21 07:12AM  
May-19-21 05:15PM  
May-11-21 06:30AM  
Apr-25-21 05:18AM  
Apr-21-21 08:00AM  
Apr-15-21 06:00PM  
Apr-12-21 01:45PM  
Mar-30-21 06:30AM  
Feb-26-21 02:24PM  
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.